{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Vaccine+2&page=9", "query": { "intervention": "Control Vaccine 2", "page": 9 }, "page_size": 10 }, "pagination": { "page": 9, "page_size": 10, "total_count": 680, "total_pages": 68, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Vaccine+2&page=10&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Vaccine+2&page=8&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-17T09:12:55.398Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04569786", "title": "Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Coronavirus Disease (COVID-19)" ], "interventions": [ { "name": "V590", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 232, "start_date": "2020-10-29", "completion_date": "2021-02-18", "has_results": true, "last_update_posted_date": "2021-12-29", "last_synced_at": "2026-10-17T09:12:55.398Z", "location_count": 7, "location_summary": "Tempe, Arizona • Miami, Florida • South Miami, Florida + 4 more", "locations": [ { "city": "Tempe", "state": "Arizona" }, { "city": "Miami", "state": "Florida" }, { "city": "South Miami", "state": "Florida" }, { "city": "Springfield", "state": "Missouri" }, { "city": "Lincoln", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT04569786" }, { "nct_id": "NCT00345683", "title": "Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Haemophilus Influenzae Type b", "Neisseria Meningitidis" ], "interventions": [ { "name": "GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined (792014)", "type": "BIOLOGICAL" }, { "name": "PedvaxHIB", "type": "BIOLOGICAL" }, { "name": "Prevnar", "type": "BIOLOGICAL" }, { "name": "M-M-R II", "type": "BIOLOGICAL" }, { "name": "Varivax", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Months", "maximum_age": "15 Months", "sex": "ALL", "summary": "12 Months to 15 Months" }, "enrollment_count": 4021, "start_date": "2007-07", "completion_date": "2008-11", "has_results": true, "last_update_posted_date": "2016-11-29", "last_synced_at": "2026-10-17T09:12:55.398Z", "location_count": 55, "location_summary": "Birmingham, Alabama • Benton, Arkansas • Jonesboro, Arkansas + 45 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Benton", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00345683" }, { "nct_id": "NCT04199689", "title": "Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Papillomavirus Infections" ], "interventions": [ { "name": "9vHPV Vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo (Saline for Injection)", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "20 Years to 45 Years · Male only" }, "enrollment_count": 6033, "start_date": "2020-02-27", "completion_date": "2027-06-01", "has_results": false, "last_update_posted_date": "2026-10-01", "last_synced_at": "2026-10-17T09:12:55.398Z", "location_count": 32, "location_summary": "Northridge, California • Rialto, California • Simi Valley, California + 28 more", "locations": [ { "city": "Northridge", "state": "California" }, { "city": "Rialto", "state": "California" }, { "city": "Simi Valley", "state": "California" }, { "city": "Spring Valley", "state": "California" }, { "city": "Walnut Creek", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04199689" }, { "nct_id": "NCT02285777", "title": "Assessing the Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Meningococcal Disease" ], "interventions": [ { "name": "Meningococcal ABCWY", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "19 Years", "sex": "ALL", "summary": "10 Years to 19 Years" }, "enrollment_count": 189, "start_date": "2014-12-01", "completion_date": "2015-06-11", "has_results": true, "last_update_posted_date": "2018-09-24", "last_synced_at": "2026-10-17T09:12:55.398Z", "location_count": 8, "location_summary": "Huntsville, Alabama • Jonesboro, Arkansas • Melbourne, Florida + 5 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Melbourne", "state": "Florida" }, { "city": "Newton", "state": "Kansas" }, { "city": "Wichita", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02285777" }, { "nct_id": "NCT06740630", "title": "A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chickenpox" ], "interventions": [ { "name": "Investigational varicella vaccine_Lot 1", "type": "BIOLOGICAL" }, { "name": "Investigational varicella vaccine_Lot 2", "type": "BIOLOGICAL" }, { "name": "Investigational varicella vaccine_Lot 3", "type": "BIOLOGICAL" }, { "name": "Marketed varicella vaccine_Lot 1", "type": "BIOLOGICAL" }, { "name": "Marketed varicella vaccine_Lot 2", "type": "BIOLOGICAL" }, { "name": "MMR vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis A vaccine", "type": "BIOLOGICAL" }, { "name": "PCV (pneumococcal conjugate vaccine) 13", "type": "BIOLOGICAL" }, { "name": "PCV 20", "type": "BIOLOGICAL" }, { "name": "Vaxneuvance", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Months", "maximum_age": "15 Months", "sex": "ALL", "summary": "12 Months to 15 Months" }, "enrollment_count": 1840, "start_date": "2025-01-10", "completion_date": "2027-05-17", "has_results": false, "last_update_posted_date": "2026-05-29", "last_synced_at": "2026-10-17T09:12:55.398Z", "location_count": 59, "location_summary": "Mobile, Alabama • Hot Springs, Arkansas • Sherwood, Arkansas + 50 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Sherwood", "state": "Arkansas" }, { "city": "Canoga Park", "state": "California" }, { "city": "Covina", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06740630" }, { "nct_id": "NCT06735209", "title": "First-in-Human PfSPZ-LARC2 Vaccination/CHMI", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Malaria" ], "interventions": [ { "name": "PfSPZ Vaccine", "type": "BIOLOGICAL" }, { "name": "PfSPZ (7G8) Challenge", "type": "BIOLOGICAL" }, { "name": "Sodium Chloride, 0.9%", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 22, "start_date": "2025-07-23", "completion_date": "2026-07-10", "has_results": false, "last_update_posted_date": "2026-08-17", "last_synced_at": "2026-10-17T09:12:55.398Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT06735209" }, { "nct_id": "NCT01997229", "title": "Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Refractory Generalized Myasthenia Gravis" ], "interventions": [ { "name": "Eculizumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 125, "start_date": "2013-12", "completion_date": "2016-06", "has_results": true, "last_update_posted_date": "2019-07-16", "last_synced_at": "2026-10-17T09:12:55.398Z", "location_count": 41, "location_summary": "Birmingham, Alabama • Fresno, California • Los Angeles, California + 35 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fresno", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01997229" }, { "nct_id": "NCT07092865", "title": "A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Respiratory Syncytial Virus Infections" ], "interventions": [ { "name": "Adjuvanted RSVPreF3 vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 168, "start_date": "2025-08-06", "completion_date": "2027-07-16", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-17T09:12:55.398Z", "location_count": 7, "location_summary": "Lexington, Kentucky • St Louis, Missouri • Omaha, Nebraska + 3 more", "locations": [ { "city": "Lexington", "state": "Kentucky" }, { "city": "St Louis", "state": "Missouri" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07092865" }, { "nct_id": "NCT06907511", "title": "Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and Older", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Pandemic Influenza Immunization", "Healthy Volunteers" ], "interventions": [ { "name": "Pandemic flu H5 HA mRNA SD2 vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 720, "start_date": "2025-04-17", "completion_date": "2026-12-01", "has_results": false, "last_update_posted_date": "2026-01-16", "last_synced_at": "2026-10-17T09:12:55.398Z", "location_count": 13, "location_summary": "La Mesa, California • DeLand, Florida • Lakeland, Florida + 10 more", "locations": [ { "city": "La Mesa", "state": "California" }, { "city": "DeLand", "state": "Florida" }, { "city": "Lakeland", "state": "Florida" }, { "city": "Largo", "state": "Florida" }, { "city": "Decatur", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06907511" }, { "nct_id": "NCT00862277", "title": "Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Meningococcal Infections", "Meningitis" ], "interventions": [ { "name": "Menactra®", "type": "BIOLOGICAL" }, { "name": "Menomune®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "14 Years", "maximum_age": "27 Years", "sex": "ALL", "summary": "14 Years to 27 Years" }, "enrollment_count": 763, "start_date": "2008-12", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2016-04-14", "last_synced_at": "2026-10-17T09:12:55.398Z", "location_count": 20, "location_summary": "Little Rock, Arkansas • Fountain Valley, California • Marietta, Georgia + 15 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Marietta", "state": "Georgia" }, { "city": "Martinez", "state": "Georgia" }, { "city": "Woodstock", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00862277" } ] }